|
|||||
|
|
TERT promoter mutations contribute to IDH mutations in predicting differential responses to adjuvant therapies in WHO grade II and III diffuse gliomas |
|
| Authors: | Zhen-Yu Zhang Aden Ka-Yin Chan Xiao-Jie Ding Zhi-Yong Qin Christopher S. Hong Ling-Chao Chen Xin Zhang Fang-Ping Zhao Yin Wang Yang Wang Liang-Fu Zhou Zhengping Zhuang Ho-Keung Ng Hai Yan Yu Yao Ying Mao |
| Abstract: | |
| Keywords: | TERT promoter IDH gliomas radiation therapy chemotherapy |